News
Guides, lab handling, storage and research insights from our team.
alcohol use disorder
Aug 05, 2026
Retatrutide in VA Alcohol Use Disorder Trials: Could the Triple-Agonist Outperform Tirzepatide for Veterans?The VA is testing retatrutide, a triple-agonist peptide, for alcohol use disorder. Could it outperform tirzepatide? This article examines the...Read article
compounding
Jul 29, 2026
Retatrutide and the FDA Peptide Panel Vote: Could Triple-Agonist Compounding Outlast Tirzepatide Shortages?The FDA's peptide panel vote could reshape compounding access for retatrutide, a triple-agonist still in trials. As tirzepatide shortages persist,...Read article
GLP-1 agonists
Jul 24, 2026
Retatrutide for Post-Ramadan Weight RegainRetatrutide, an investigational triple agonist, may help mitigate semaglutide resumption intolerance after Ramadan. This article examines the regulatoryRead article